5-オキソ-L-Pro-L-Arg-L-Pro-L-Pro-L-Met-L-Glu-L-Glu-L-Glu-L-Glu-L-Glu-L-Ala-L-Tyr-Gly-L-Trp-L-Met-L-Asp-L-Phe-NH2
5-オキソ-L-Pro-L-Arg-L-Pro-L-Pro-L-Met-L-Glu-L-Glu-L-Glu-L-Glu-L-Glu-L-Ala-L-Tyr-Gly-L-Trp-L-Met-L-Asp-L-Phe-NH2 物理性質
- 比重(密度) :
- 1.55±0.1 g/cm3(Predicted)
- 貯蔵温度 :
- −20°C
- 溶解性:
- Soluble in DMSO
- 外見 :
- Solid
- 酸解離定数(Pka):
- 4.19±0.10(Predicted)
安全性情報
5-オキソ-L-Pro-L-Arg-L-Pro-L-Pro-L-Met-L-Glu-L-Glu-L-Glu-L-Glu-L-Glu-L-Ala-L-Tyr-Gly-L-Trp-L-Met-L-Asp-L-Phe-NH2 価格
もっと(6)
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01LKTG0179 |
ガストリン-1, ラット
Gastrin-1, rat |
81123-06-0 |
0.5mg |
¥30500 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01LKTG0179 |
ガストリン-1, ラット
Gastrin-1, rat |
81123-06-0 |
1mg |
¥50800 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01LKTG0179 |
ガストリン-1, ラット
Gastrin-1, rat |
81123-06-0 |
2.5mg |
¥97400 |
2024-03-01 |
購入 |
Sigma-Aldrich Japan
|
G1276 |
ガストリンI ラット ≥97% (HPLC)
Gastrin I rat ≥97% (HPLC) |
81123-06-0 |
250μg |
¥93700 |
2024-03-01 |
購入 |
Sigma-Aldrich Japan
|
G1276 |
ガストリンI ラット ≥97% (HPLC)
Gastrin I rat ≥97% (HPLC) |
81123-06-0 |
1mg |
¥171000 |
2024-03-01 |
購入 |
5-オキソ-L-Pro-L-Arg-L-Pro-L-Pro-L-Met-L-Glu-L-Glu-L-Glu-L-Glu-L-Glu-L-Ala-L-Tyr-Gly-L-Trp-L-Met-L-Asp-L-Phe-NH2 化学特性,用途語,生産方法
使用
Gastrin I (rat) has been used in a study for gastrin stimulation in rats to determine the expression of histidine decarboxylase and histamine metabolism in gastric oxyntic mucosa during conditions of hypergastrinemia and carcinoid tumor. It has also been used for preabsorption of anti-gastrin antibody prior to immunohistochemical assay in rats.
一般的な説明
Gastrin is a pyloric antral hormone, which is a small biologically active peptide thatis synthesized as a precursor. It is found to be produced in antral G cells.
Biochem/physiol Actions
Gastrin plays a crucial role in the maintenance of architecture and function of oxyntic mucosa of stomach, which is involved in the secretion of acid. It also triggers the secretion of acid into the gastric lumen. Continuous increased plasma levels of gastrin or hypergastrinemia, may be involved in gastrointestinal carcinogenesis, especially if it is accompanied with inflammation. The release of this peptide is suppressed during distention, which is a result of omatostatin and intrinsic cholinergic pathways. In rats, this peptide maintains gastric mucosal integrity through the up-regulation of cyclooxygenase-2 which is, in part, mediated by heparin-binding epidermal growth factor-like growth factor (HB-EGF).
5-オキソ-L-Pro-L-Arg-L-Pro-L-Pro-L-Met-L-Glu-L-Glu-L-Glu-L-Glu-L-Glu-L-Ala-L-Tyr-Gly-L-Trp-L-Met-L-Asp-L-Phe-NH2 上流と下流の製品情報
原材料
準備製品
5-オキソ-L-Pro-L-Arg-L-Pro-L-Pro-L-Met-L-Glu-L-Glu-L-Glu-L-Glu-L-Glu-L-Ala-L-Tyr-Gly-L-Trp-L-Met-L-Asp-L-Phe-NH2 生産企業
Global( 102)Suppliers
81123-06-0(5-オキソ-L-Pro-L-Arg-L-Pro-L-Pro-L-Met-L-Glu-L-Glu-L-Glu-L-Glu-L-Glu-L-Ala-L-Tyr-Gly-L-Trp-L-Met-L-Asp-L-Phe-NH2)キーワード:
- 81123-06-0
- GASTRIN (RAT)
- GASTRIN, RAT (1-17)
- PYR-ARG-PRO-PRO-MET-GLU-GLU-GLU-GLU-GLU-ALA-TYR-GLY-TRP-MET-ASP-PHE-NH2
- PYR-RPPMEEEEEAYGWMDF-NH2
- PGLU-ARG-PRO-PRO-MET-GLU-GLU-GLU-GLU-GLU-ALA-TYR-GLY-TRP-MET-ASP-PHE-NH2
- 5-Oxo-L-Pro-L-Arg-L-Pro-L-Pro-L-Met-L-Glu-L-Glu-L-Glu-L-Glu-L-Glu-L-Ala-L-Tyr-Gly-L-Trp-L-Met-L-Asp-L-Phe-NH2
- Gastrin I heptadecapeptide【rat】
- GASTRIN (1-17), RAT
- GASTRIN I (RAT)
- GASTRIN-1, RAT
- GASTRIN I
- GASTRIN I RATGASTRIN
- PYR-ARG-PRO-PRO-MET-GLU-GLU-GLU-GLU-GLU-ALA-TYR-GLY-TRP-MET-ASP-PHE-NH2 USP/EP/BP
- Gastrin I, rat, ≥97% (HPLC)
- Gastrin-17 I (rat) (9CI)
- ガストリンIヘプタデカペプチド【ラット】
- ガストリンI【ラット】
- 5-オキソ-L-Pro-L-Arg-L-Pro-L-Pro-L-Met-L-Glu-L-Glu-L-Glu-L-Glu-L-Glu-L-Ala-L-Tyr-Gly-L-Trp-L-Met-L-Asp-L-Phe-NH2
- ガストリン-1, ラット
- ガストリンI ラット